Antigens are usually poorly immunogenic when administered orally or in
tranasally and a variety of approaches have been designed to overcome
this problem. Recently, the progress of six projects involving 24 labo
ratories funded by the 'Human and Veterinary Vaccines' section of the
EC-Biotechnology programme were discussed at a meeting in Luxembourg.